(Q38123245)

29 August 2017

title

Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity (English)

1 reference

29 August 2017

0 references

1 reference

Antonio Macciò

1

1 reference

29 August 2017

Clelia Madeddu

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

22 July 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

published in

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

13

1 reference

29 August 2017

page(s)

1839-1857

1 reference

The resurgence of platinum-based cancer chemotherapy

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Subcellular targets of cisplatin cytotoxicity: an integrated view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin cytotoxicity: DNA and plasma membrane targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Glucose metabolism in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Dichloroacetate induces apoptosis in endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Glucose intolerance following cis-platinum treatment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Acute renal failure: from renal physiology to the renal transcriptome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Akt stimulates aerobic glycolysis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Mitochondrial STAT3 supports Ras-dependent oncogenic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Detection and cytotoxicity of cisplatin-induced superoxide anion in monolayer cultures of a human ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Free radicals and antioxidants: updating a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Tubular cell damage in acute renal failure-apoptosis, necrosis, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Regulation and pathological role of p53 in cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

How many cisplatin administration protocols does your department use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin-associated anemia: an erythropoietin deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Effects of pro- and antioxidative compounds on renal production of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Brain areas essential or non-essential for emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Antiemetics: an update and the MASCC guidelines applied in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Neurochemistry and neuropharmacology of emesis - the role of serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

5-HT3 receptor antagonists: differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The central role of glutathione in the pathophysiology of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Effects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Redox regulation of cell functions by alpha-lipoate: biochemical and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Redox regulation of NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Comparative Effects of Alpha Lipoic Acid and Melatonin on Cisplatin-Induced Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Amifostine: the first selective-target and broad-spectrum radioprotector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

ACTH/MSH like peptides in the treatment of cisplatin neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Resveratrol attenuates cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Naringenin attenuates cisplatin nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Clinical applications of PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

A new dimension of FDG-PET interpretation: assessment of tumor biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Lack of Tocopherol in Peripheral Nerves of Vitamin E-Deficient Patients with Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813934

Serotonin receptor antagonists for highly emetogenic chemotherapy in adults

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD006272.PUB2

10.1517/14656566.2013.813934

12 January 2024

Identifiers

DOI

1 reference

29 August 2017

1 reference